Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Obstet Gynecol ; 213(6): 871.e1-3, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26363477

ABSTRACT

Chronic pelvic pain can result from noncommunicating uterine cavities in patients with müllerian anomalies. Traditional management has been to resect the noncommunicating uterine horn. Two cases are described. One had a unicornuate uterus with noncommunicating left uterine horn (American Fertility Society [AFS] classification IIb) and the other had a normal external uterine contour with noncommunicating left uterine cavity that did not fit any category of the AFS classification of müllerian anomalies. Attempts at connecting the noncommunicating cavities hysteroscopically failed in both cases. Successful unification of the cavities was subsequently achieved in the first case using the classic Strassman metroplasty with the assistance of the robot. The unification of uterine cavities was achieved using a modified Strassman metroplasty in the second patient, as there was no uterine horn for landmark. Robot assistance was utilized in this case as well. Both patients are symptom free after surgery. We conclude that laparoscopic Strassman metroplasty, with or without robot assistance, is a viable alternative to resection of uterine horns in patients with hematometra, chronic pelvic pain, and noncommunicating uterine cavities.


Subject(s)
Chronic Pain/surgery , Pelvic Pain/surgery , Uterus/abnormalities , Uterus/surgery , Adolescent , Chronic Pain/etiology , Female , Hematometra/surgery , Humans , Pelvic Pain/etiology , Young Adult
2.
J Reprod Med ; 53(9): 667-71, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18839818

ABSTRACT

OBJECTIVE: To examine the impact of maternal prepregnancy body mass index (BMI) on rates of recurrent preterm delivery (PTD) in women receiving 17alpha-hydroxyprogesterone caproate (17P) prophylaxis. STUDY DESIGN: The study population was identified from a large perinatal database containing prospectively collected information from women at high risk for PTD. We included patients with a current singleton pregnancy and a history of PTD who received weekly nursing visits and 17P 250 mg intramuscular injections beginning at 16.0 to 20.9 weeks' gestation. The data were stratified by number of prior PTDs (1 or >1) and maternal prepregnancy BMI (lean, normal, overweight and obese). Primary study outcomes included the rates of recurrent PTD at <35 and 32 weeks' gestation, and pregnancy loss at <24 weeks' gestation. RESULTS: Delivery outcomes for 606 women receiving 17P were analyzed. There were no significant differences found in the incidence of preterm labor, the rates of recurrent PTD or pregnancy loss at <35, 32 or 24 weeks between the BMI groups. CONCLUSION: Maternal prepregnancy BMI does not appear to influence the rates of recurrent PTD in women with singleton gestation receiving 17P prophylaxis. Larger studies are needed to confirm our findings.


Subject(s)
Body Mass Index , Hydroxyprogesterones/therapeutic use , Premature Birth/prevention & control , Tocolytic Agents/therapeutic use , 17 alpha-Hydroxyprogesterone Caproate , Adult , Female , Humans , Pregnancy , Prospective Studies , Secondary Prevention , Young Adult
3.
Dermatol Online J ; 14(1): 2, 2008 Jan 15.
Article in English | MEDLINE | ID: mdl-18319019

ABSTRACT

Vulvodynia or vulvar pain syndrome is a chronic, heterogeneous, and multifactorial disease with a high prevalence. This condition affects Caucasians, African Americans, Africans and Hispanic women, particularly those sexually active at child-bearing age. The etiology of this condition is complex and remains elusive. An accurate diagnosis requires a comprehensive history, physical examination and targeted diagnostic tests. Although many treatment options have been utilized, a rational therapeutic strategy is still under research. Psychological counseling and group support should be considered in all cases.


Subject(s)
Pain Management , Pain/etiology , Vulvar Diseases/complications , Vulvar Diseases/therapy , Female , Humans , Pain/psychology , Physical Examination , Sexual Dysfunction, Physiological , Stress, Psychological/etiology , Stress, Psychological/therapy , Vulvar Diseases/psychology
4.
Am J Obstet Gynecol ; 187(6): 1521-7, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12501056

ABSTRACT

OBJECTIVE: The purpose of this study was to evaluate the effectiveness of the Society of Pelvic Reconstructive Surgeons guidelines for the determination of the route of hysterectomy in a resident clinic population. STUDY DESIGN: A total of 407 consecutive women from the resident clinic population at Wright State University between October 1, 1994, and December 31, 1999, were assigned prospectively to abdominal or vaginal hysterectomy groups according to Society of Pelvic Reconstructive Surgeons guidelines. The women's age, race, and preoperative and postoperative uterine weights, length of stay, laparoscopic scores, operative time, and complications were compared. RESULTS: Vaginal hysterectomy was completed successfully in 91.8% of the women. As expected, vaginal hysterectomy required the shortest operative time and length of stay and was associated with fewer complications than the abdominal approach (P <.01). Laparoscopic assistance was necessary in 25.8% of patients to assess extrauterine disease. CONCLUSION: Resident physicians who followed the practice guidelines reduced the ratio of abdominal-to-vaginal hysterectomy from 3:1 to 1:11. The application of practice guidelines for the selection of the route of hysterectomy can increase the ratio of vaginal hysterectomies that are performed in residency programs and can help eradicate inconsistencies in health care delivery that exist currently.


Subject(s)
Hysterectomy/methods , Internship and Residency , Practice Guidelines as Topic , Adult , Evidence-Based Medicine , Female , Genital Diseases, Female/pathology , Genital Diseases, Female/surgery , Humans , Hysterectomy, Vaginal/methods , Laparoscopy , Length of Stay , Postoperative Complications/epidemiology , Time Factors , Uterine Diseases/pathology , Uterine Diseases/surgery , Uterus/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...